In-use test to study the user rating for Plum Niacinamide Tinted Sunscreen
Overview
- Phase
- Post Marketing Surveillance
- Status
- Completed
- Sponsor
- Pureplay Skin Sciences Pvt Ltd
- Enrollment
- 32
- Locations
- 1
- Primary Endpoint
- User Ratings
Overview
Brief Summary
It is a User Rating based trial where, healthy volunteers are enrolled
Consumer self evaluation were assesses-
-
X% users felt their skin looked instantly bright and even toned.
-
X% said the formula blended seamlessly into their skin tone.
-
X% users agreed that the sunscreen is perfect for Indian skin tones.
-
X % users agreed that the sunscreen enhanced skin smoothness and visibly blurred skin texture
-
X% found the sunscreen lightweight and comfortable for all-day wear.
-
X% said their skin felt hydrated and smooth without greasiness.
-
X% agreed it provided reliable protection throughout the day without needing frequent reapplication.
-
X% noticed brighter and healthier-looking skin after X days of regular use.
-
X% confirmed the tint adapted well to their skin tone, leaving no white cast.
-
X% users confirmed that their makeup didn’t budge after using this sunscreen as base.
Study Design
- Study Type
- Pms
- Allocation
- Na
- Masking
- None
Eligibility Criteria
- Ages
- 18.00 Year(s) to 45.00 Year(s) (—)
Inclusion Criteria
- •Gender: Non-pregnant, non-lactating female aged between 18 to 45 (Female:Male ratio to be 80:20) 2) Subjects willing to give written informed consent 3) Women of child bearing potential must have a negative urine pregnancy test prior to study entry.
- •Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
- •Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.
Exclusion Criteria
- •1.Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study.
- •2.Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
- •3.Have open sores or open lesions in the treatment area(s).
- •4.Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product.
- •5.Have participated in any interventional clinical trial in the previous 30 days.
- •6.Have a known sensitivity to any of the constituents of the test product including sensitivities to (mention some of active ingredient’s name) 7.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
- •8.Have a history of alcohol or illegal drug/substance abuse, or suspected alcohol or illegal drug/substance abuse in the past 2 years.
Outcomes
Primary Outcomes
User Ratings
Time Frame: T+7days
Secondary Outcomes
- Not Applicable(Not Applicable)
Investigators
Dr Robin Chugh
CCFT Laboratories